Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and misoprostol for prevention of postpartum hemorrhage at cesarean section
ACTRN12612000095864Phase 2Not yet recruiting
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin and misoprostol in postpartum hemorrhage (PPH) (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Change in hemoglobin level after delivery, Estimated blood loss at cesarean section and 1 more. Planned start Feb 2012; status: not yet recruiting.
02
Drugs
oxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12612000095864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000095864.